Back

Invivyd to participate in three investor conferences in New York

Verifying
  • Invivyd will participate in three investor conferences alongside management meetings and fireside chats.
  • September 9 through September 14, 2026, covers the company’s scheduled conference appearances.
  • Invivyd received U.S. FDA emergency use authorization for a monoclonal antibody in March 2024.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.